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Background-—Rheumatic heart disease is a high-burden condition in Australian Aboriginal communities. We evaluated a stepped-
wedge, community, randomized trial at 10 Aboriginal communities from 2013 to 2015. A multifaceted intervention was
implemented using quality improvement and chronic care model approaches to improve delivery of penicillin prophylaxis for
rheumatic heart disease. The trial did not improve penicillin adherence. This mixed-methods evaluation, designed a priori, aimed to
determine the association between methodological approaches and outcomes.
Methods and Results-—An evaluation framework was developed to measure the success of project implementation and of the
underlying program theory. The program theory posited that penicillin delivery would be improved through activities implemented
at clinics that addressed elements of the chronic care model. Qualitative data were derived from interviews with health-center
staff, informants, and clients; participant observation; and project officer reports. Quantitative data comprised numbers and types
of “action items,” which were developed by participating clinic staff with project officers to improve delivery of penicillin injections.
Interview data from 121 health-center staff, 22 informants, and 72 clients revealed barriers to achieving the trial’s aims, including
project-level factors (short trial duration), implementation factors (types of activities implemented), and contextual factors (high
staff turnover and the complex sociocultural environment). Insufficient actions were implemented addressing “self-management
support” and “community linkage” streams of the chronic care model. Increased momentum was evident in later stages of the
study.
Conclusions-—The program theory underpinning the study was sound. The limited impact made by the study on adherence was
attributable to complex implementation challenges. ( J Am Heart Assoc. 2018;7:e009376. DOI: 10.1161/JAHA.118.009376.)
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R heumatic heart disease (RHD) comprises damage tocardiac valves during episodes of acute rheumatic fever
(ARF) following group A streptococcal infection. More than 33
million people have RHD globally, causing >10 million
disability-adjusted life-years lost and >300 000 deaths
annually.1 In June 2017, the World Health Organization
executive board recommended that a resolution on ARF and
RHD be put to the World Health Assembly in 2018 to call on
nations to implement evidence-based approaches to RHD
control. To date, little research has been done on health
systems approaches to improving RHD care and prevention.
In the Northern Territory (NT) of Australia, efforts to control
RHD need to take into consideration important sociocultural
and economic factors underpinning high disease rates. The
major current focus of RHD control in Australian NT Aboriginal
communities is secondary prevention, consisting of long-term
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injections of long-acting intramuscular benzathine penicillin
administered every 4 weeks. This treatment is delivered by
healthcare providers in primary care clinics serving local
communities, supported by a centralized register-based RHD
control program. Delivery of secondary prophylaxis is chal-
lenging, with the majority of ARF and RHD clients receiving
less than half their scheduled injections and less than a third
receiving the recommended ≥80% (M. Fittock, Registered
Nurse, NT RHD Control Program, unpublished data, 2011).2
To improve delivery of ARF/RHD secondary prophylaxis, a
comprehensive health-system–strengthening strategy was
developed and evaluated in a stepped-wedge, community,
randomized trial in 10 sites in Australia’s NT between 2013
and 2016 (RHDSP [Rheumatic Heart Disease Secondary
Prophylaxis] trial).3,4 The trial was powered to detect doubling
of the proportion of clients getting ≥80% of scheduled penicillin
injections from 20% to 40%. All sites received a multifaceted
intervention using continuous quality improvement (CQI) pro-
cesses and activities aligned with streams of the chronic care
model (CCM). The CCM is an approach to chronic illness
management in primary care settings to create an “informed,
activated patient and a prepared, proactive practice team” by
addressing health systems, delivery system design, decision
support, clinical information systems, self-management sup-
port, and community linkages.5ARFandRHD fulfill thedefinition
ofchronicconditionsbecausemanagement includesaminimum
of 10 years of antibiotic administration as secondary prophy-
laxis for ARF recurrences, as well as other long-term regular
medical interventions.6 The CCM appears to be highly suited to
delivery of care for ARF and RHD.7
Key findings from the RHDSP trial, reported in detail
elsewhere,4 indicated that there was high variation in delivery
of penicillin prophylaxis for ARF and/or RHD between sites, and
the intervention did not improve penicillin adherence; in fact,
adherence was slightly lower during the intensive phase of the
trial (126/304 [41%] receiving the target of ≥80% of scheduled
injections) compared with baseline (141/304 [46%], not a
statistically significant difference). Adherence at baseline was
already better than expected at 46%, compared with 23%
previously (M. Fittock, Registered Nurse, NT RHD Control
Program, unpublished data, 2011). Although the trial did not
make further overall improvements, the subset of patients in the
most adherent category (≥90% of scheduled injections) signif-
icantly increased during the maintenance phase. With only 10
participating sites and multiple differing characteristics of
clinics, includingpatient numbersper site, level of staff turnover,
socioeconomic indicators, numbers of action items completed,
number of intervention visits achieved by the project officers,
and clinic governance structure, no statistically significant
associations could be identified between clinic characteristics
and adherence outcomes. The 6 community-controlled organi-
zations performed similarly to the 4 government-run services.
Recognizing the methodological, pragmatic, and theoretical
limitations of randomized trials in evaluating complex health
interventions,8 a comprehensive mixed-method evaluation
was designed at the outset to ensure that the trial’s findings
would be understood in depth. The aim of this article is to
report qualitative findings of the evaluation framework that
were collected during the trial to understand factors that
affected the trial’s implementation and outcomes. These
findings have implications broadly across diverse settings
aiming to improve health systems approaches to RHD control.
Methods
Trial Design
NT Aboriginal community clinics were invited to participate;
10 sites (sites A–J) consented, providing 304 clients.4 The
Clinical Perspective
What Is New?
• Creative and comprehensive approaches tailored for young
people often living in disadvantaged and culturally diverse
settings are needed to support their adherence to long-term
penicillin to prevent rheumatic heart disease; the chronic
care model provides a helpful scaffold.
• This evaluation showed that health-system–strengthening
activities at primary care centers can fail to change
outcomes for clients if strategies are insufficient to
successfully engage the community and provide chronic
disease self-management support.
• Qualitative evaluation embedded in a randomized trial
provides in-depth understanding of outcomes and study
context, including whether findings could be attributed to
project design factors and how implementation occurred.
What Are the Clinical Implications?
• Use of incentives and removal of disincentives to receive
penicillin injections were implemented, but their impact on
measurable adherence was low because clients often lacked
understanding of the value of the injections; this was
attributable to impaired communication between healthcare
providers and clients, in turn due to fundamental differences
in culture and language, compounded by high staff turnover.
• Organizations that are culturally responsive and that
support continuous learning and quality improvement can
achieve better outcomes for clients.
• Continuous quality-improvement cycles to motivate change
can take time (>12 months) before improvements are seen.
• Community-led, codesigned models of care are now being
piloted, and innovative adherence support tools such as
smartphone applications are gaining traction.
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required sample size was 300 clients.3 Pairs of sites entered
the trial in random order according to a stepped-wedge design
at 3-month intervals. A stepped-wedge trial is a type of cluster
randomized trial in which clusters receive the intervention at
different time points, in random order, and comparisons are
made between trial phases rather than between intervention
and control sites.3,9 This approach was chosen because it
allows all sites to receive the intervention by the end of the
study. Trial phases comprised (1) baseline data collection
(12 months), (2) a transition phase with commencement of
intensive phase activities but exclusion of data from outcome
analyses (3 months), (3) an intensive phase (12 months), and
(4) a maintenance phase (3–15 months depending on each
site’s start date).3 The variable duration of the maintenance
phase is a consequence of the staggered commencement
dates owing to the stepped-wedge design.
The multifaceted intervention utilized quality-improvement
cycles and activities in all domains of the CCM including staff
education and training. CQI processes aim to engage staff in
understanding and responding to their own data and can be a
powerful tool to motivate change in primary care settings.10
We previously showed incremental improvements in clinical
care targets achieved in RHD management using CQI.2
Processes included proactive use of adherence data from
each participating clinic to motivate healthcare providers and
managers to work toward improved penicillin delivery targets,
specifically, for more clients to achieve ≥80% of scheduled
injections. Project officers presented clinics with quarterly
data in simple graphics at face-to-face workshops throughout
the intensive phase. To reach improved targets, each clinic
developed and implemented a set of activities or action
items.3,4 Action items were compiled into action plans, aligned
with the streams of the CCM, that would help the clinic to
deliver the penicillin injections more effectively. Staff support
included encouragement to undertake online training modules
on ARF and RHD11 and on self-management support and to
integrate evidence-based guidelines into daily clinical practice
using online resources6 or smartphone applications.12 A
quarterly study newsletter was produced to share ideas for
strengthening the delivery of RHD prevention and to foster
engagement with and ownership of the project by participating
sites. It was circulated to participating sites and stakeholders
throughout the study.
A program theory was developed, as we have described
previously,3 to illustrate how the CCM would be translated into
activities that would affect delivery of penicillin secondary
prophylaxis for ARF and/or RHD clients by participating
clinics. A program theory is a plausible model of how a program
should work and provides a foundation on which a theory-
driven evaluation framework can be constructed.13 It
described the prescriptive assumptions of the project (ie,
What action is required to improve adherence to ARF/RHD
secondary prophylaxis?) and descriptive assumptions (ie, Why
will adherence be affected by these actions?). An example of
an activity addressing the decision support stream of the CCM
would be one that ensures all healthcare staff receive regular
training in delivery of prophylaxis for RHD. An activity
addressing the clinical information systems stream might be
one that improves electronic systems to provide automated
recalls for clients when prophylaxis is due. Both activities
would be expected to lead to improved delivery of the required
treatment.
To capture client perspectives, a nested focused ethno-
graphic study (a description of cultural behavior focusing on
ARF and RHD) was conducted at communities A, C, D, and G.
These sites were chosen based on accessibility and language—
different languages are spoken in different communities in the
NT, and the researcher spoke 1 Aboriginal language. It used an
exploratory approach to the phenomenon of the long-term
penicillin regimen to investigate client perspectives including
what they understood and experienced of ARF and/or RHD,
what their healthcare experiences were, how their age and
culture influenced their self-care, and what community- and
clinic-level factors facilitated their self-care.
Approval was provided by the human research ethics
committee of the NT Department of Health and Menzies
School of Health Research (no. 2012-1756) and the Central
Australian Human Research Ethics Committee (no. 2013-
126). The data will not be made available to other
researchers because interview participants consented for
their interview material to be available to only nominated
study investigators.
Participants
Staff participants were eligible for interview if they were
healthcare providers or ancillary staff working at participat-
ing clinics (doctors, nurses, Aboriginal health practitioners,
clinic drivers [Aboriginal community members], reception-
ists), key stakeholders (NT RHD control program, working in
remote health governance), or community informants (eg,
teacher at a participating site). Two project officers
employed by the project were also invited to be interviewed
at the trial’s conclusion. Individual written informed consent
was sought to undertake and audio-record interviews. Client
participants were eligible to be interviewed if they resided at
1 of the 4 participating communities at which the ethno-
graphic study was undertaken, were aged 5 to 35 years,
and were currently prescribed intramuscular penicillin for
ARF and/or RHD prophylaxis. An audio recording that
explained the study and sought consent in 1 Aboriginal
language was also used. Interviews were audio-recorded and
transcribed or were hand written if consent for audio
recording was not provided.
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Data Sources
Data comprised semistructured interviews, project officer
reports, observations, clinic action plan documents, and team
meeting notes. In semistructured interviews, staff perspec-
tives were sought at baseline regarding barriers to and
enablers of delivering ARF/RHD prophylaxis and during the
maintenance phase about their experience of the trial. The
same staff members were interviewed serially if possible, but
staff turnover meant this was not usually possible. In the
nested ethnographic study, semistructured interviews and
participant observations were carried out with young Aborig-
inal clients and their families at communities A, C, D, and G
throughout the duration of the study.
The project officers were research nurses who visited the
participating sites to support implementation of the interven-
tion. They produced monthly reports and quarterly summaries
including observation and informal discussion. They also
documented clinic action plans and progress against individ-
ual action items. Individual action items were classified as
completed, deleted, or ongoing, and for each, barriers and
enablers were documented. Team meeting notes were
generated from quarterly trial investigator meetings.
Qualitative Analyses
Analysis of interview data from clinic staff members and key
stakeholders was undertaken by 3 analysts (2 postdoctoral
qualitative researchers [C.R. and C.S.] and 1 mixed-methods
doctoral researcher [D.H.]) independent of the data-collection
processes and trial implementation, using a confirmatory
approach. In other words, the analysis was guided by a
specific hypothesis, and analysis codes were prespecified to
answer defined research questions and then applied to the
data, as appropriate (Figure 1).14 The hypothesis to be
explored was whether the systems-based intervention would
improve adherence to secondary prophylaxis for RHD. For
client data, responses were coded inductively and analyzed
thematically by the qualitative doctoral researcher (A.G.M.)
who conducted the interviews. For this component, an
exploratory inductive approach was used because there was
no preexisting hypothesis of how clients would respond to the
intervention—that is, codes were developed de novo from the
data without prespecified questions or assumptions. QSR
International’s NVivo 10 software was used to organize
qualitative data.
Evaluation
We developed a prespecified evaluation framework using the
program theory described earlier, and based on implementa-
tion research concepts described elsewhere,15,16 to deter-
mine what factors at health-system, patient, and project levels
affected the intervention’s implementation and outcomes. The
evaluation framework (Figure 2) sought to answer how and
why the intervention might affect clinic performance by
assessing the degree of project success at the levels of
implementation, action theory (whether activities undertaken
resulted in a more prepared and proactive practice team and
more engaged clients), and conceptual theory (whether a
more prepared and proactive practice team and more
engaged clients influenced adherence). External moderators
accounted for included environment, organization factors, and
team factors. Evaluation measures were categorized under
the headings of efficiency, effectiveness, impact, relevance,
and sustainability (Table 1). Implementation process was
measured according to fidelity to the trial protocol (develop-
ment and implementation of relevant action plans), “dose” of
the intervention (number of face-to-face visits by project
officers to participating sites), “reach” (the number and quality
of action items and comprehensiveness across the CCM
themes), and acceptability of the project.
Methods used to ensure robustness of the qualitative
analyses included independent analysis of interview and
observational data by qualitative data analysts who did not
participate directly in conducting the trial; triangulation by
using diverse sources of data, a number of collaborative
investigators, and different methodological approaches; and
peer debriefing, that is, ongoing dialogue among the project
officers, investigators, and qualitative data analysts to ensure
that information had not been misinterpreted.
Role of the Funding Source
The study was funded by the Australian National Health and
Medical Research Council and Wesfarmers Center for Vacci-
nes and Infectious Diseases at Telethon Kids Institute. The
funders had no role in the study design, data collection,
analysis, interpretation, or writing of this report.
Results
Primary healthcare services participating in the RHDSP trial
were located in 10 rural, remote, or very remote Aboriginal
communities in the Australian NT (Figure 3). Consenting
interview participants during the baseline phase comprised
107 clinic staff members working at the trial sites, 10 key
informants, and 5 community stakeholders. During the
maintenance phase, interviewees comprised 38 clinic staff
members (24 of whom had also been interviewed during
baseline) and 7 key informants (all of whom had also been
interviewed during baseline). Within the nested ethnographic
study, 72 clients (people with ARF and/or RHD or their family
members) were interviewed. Fifty quarterly project officer
reports provided field observation and data on monitoring of
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study progress. Ten documents, 1 from each site, reported on
the development and implementation of action plans to
improve the delivery of penicillin prophylaxis for clients with
ARF and/or RHD.
Efficiency
During the transition and intensive phases of the trial
(15 months), 252 action items were proposed for implemen-
tation by healthcare providers.4 Of these, 109 (43%) were
completed (Tables 2 and 3, Figure 4). Of the completed
items, 45 were categorized by project officers as preparatory
and 64 as core actions. This categorization provided a way to
help staff see momentum in progression of their action plan,
working through small, manageable preparatory steps, as
applicable, before being able to implement the core action.
Completing core actions by the end of the intervention phase
was challenging. As an example, one site devised an action
item of hosting an RHD community event; preparatory actions
included workshopping different ideas for the event, but the
event had not occurred by the end of the intensive phase
(although it did occur in the maintenance phase). There was
variation among the 10 participating sites in the number of
core action items completed (between 1 and 13) and in the
Baseline 
phase
Intensive 
phase
Maintenance 
phase
Perceived 
strategies to 
improve RHD 
delivery of care
Baseline 
knowledge 
of RHD
Baseline RHD 
delivery of 
care 
processes
Barriers & 
enablers to SP 
delivery & 
adherence
Organizaonal 
change in RHD 
delivery of care
Improvements in 
RHD delivery of 
care
Sustained 
changes
Contextual 
factors
Implementaon 
& achievement 
of intervenon 
acons
BarriersEnablers
Health 
Systems
Delivery 
Systems Design
Decision 
support
Clinical 
Informaon 
Systems
Self 
management 
support
Community 
Linkages
Environmental
Team 
factors Organizaonal
Figure 1. Coding map showing analysis codes applied to interview data from clinic staff members and key stakeholders. RHD indicates
rheumatic heart disease; SP, secondary prophylaxis.
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ability of the accomplished actions to directly affect adher-
ence; for instance, the action item “consult with the local
school about the feasibility of injection administration at the
school” did not lead to improved adherence because that
school did not support delivery of injections, whereas a plan
to “ensure that triage and other processes for clients are fast
tracked” was likely to reduce the chance of a client leaving
before receiving an injection. Some changes made by clinics
were very visible, such as construction of a new cubicle in the
waiting room to facilitate efficient injection delivery at one
site.
Almost half the completed core action items (29/64, 45%)
were dedicated to the CCM theme of clinical information
systems, followed by decision support (25%) and delivery
system design (15%; Table 2). In contrast, the community
linkages and self-management support themes received little
attention (6% each). According to the program theory we
devised3 and previous studies using the CCM framework,17,18 a
breadth of activities across the CCM is required to adequately
effect change; therefore, the intervention as implemented
lacked reach and, consequently, was inefficient in affecting the
determinants of “prepared and proactive practice teams” and
“better informed and engaged clients” (Figure 4). This was
likely to have been amajor contributor to lack of achievement of
that trial’s primary outcome of a doubling in the proportion of
clients getting ≥80% of scheduled penicillin injections.
Figure 2. Evaluation framework. The central panel illustrates the interaction between implementation (delivery of the intervention to clients),
intervention (the agents of change that affect determinants), determinants (change mechanisms), and outcomes (improved adherence).
Underpinning theories (right panel) are action theory (the intervention’s power to affect determinants) and conceptual theory (the determinant’s
ability to affect outcomes). External moderators to be accounted for (the environment, organization factors, and team factors) are shown at left.
ARF indicates acute rheumatic fever; CCM, chronic care model; RHD, rheumatic heart disease; SP, secondary prophylaxis.
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A strength of the action items was that these were usually
highly specific to context, having been devised by staff
familiar with RHD program delivery in their setting who could
recognize the gaps needing attention. However, many were
fairly minor, unable to therefore collectively lead to genuine
health system change.
Effectiveness
Owing to the lack of reach of the intervention (ie, number and
quality of action items and comprehensiveness across the
CCM themes), effectiveness of the intervention was curtailed.
Nevertheless, although the action items implemented did not
lead to improved adherence overall, there were examples of
changes in practice that had an observed positive effect on
processes of care. Examples include development of client
recall lists and updating of client records to streamline recall
processes. More accurate patient data and improvements in
the organization and use of patient data facilitated more
efficient and effective care. Clinics were widely encouraged to
start recalling patients for their next injection from day 21
after a previous injection to ensure that the next dose was
achieved within the recommended 28-day time frame.
Table 1. Framework Used for Qualitative Data Collection and Analysis for Evaluation of the RHDSP Trial
Evaluative Criteria Research Question Indicator Data Source
Efficiency:
Degree to which inputs have
been converted into outputs
To what extent did health centers
change their delivery of RHD care
to align with the systems-based
intervention?
Level of change:
Number and quality of action items
adopted; Streams of the CCM
addressed by the action items
Health center action plans; Project officer
reports (observation); Project officer
interviews; Client interview data from
ethnographic study; Team meeting notes;
Baseline and maintenance-phase interviews;
Comparison of baseline report and
maintenance-phase reports; Comparison of
quantitative findings from the analysis of the
main trial with qualitative verification
measures
Effectiveness:
The extent to which the
intervention’s objectives were
achieved
To what degree did adopting the
systems-based intervention
improve processes of RHD care
and adherence to secondary
prophylaxis? Which elements of
the intervention were most
effective in activating change?
Level of improvement to processes:
Association between components of
CCM with primary outcome (SP
adherence); Evaluation of program
theory components, its causal
processes, and expected outputs
of the CCM
Impact and relevance:
The long-term effects produced
by the intervention and the
extent to which the objectives
of the intervention are
consistent with beneficiaries’
needs
Did the intervention to strengthen
the primary care-level health
system improve overall adherence
to SP for RHD and minimize “days
at risk?”
Measure of outcomes; Proportion of
clients receiving 80% or more of
scheduled penicillin injections over
a minimum 12-mo period (see
outcome indicators for secondary
indicators); Relation of outcome
measures to implementation and
intervention activities
(completeness)
Sustainability:
The continuation of benefits
from the intervention after the
intervention has been
completed
Which of the activities and streams
of the CCM were sustained during
maintenance phase?
Level of sustained change:
Number of activities of CCM
sustained; Number of streams of
the CCM from which the activities
were adopted sustained
Project officer reports (observation); Project
officer notes of interaction with clinic staff
during the maintenance phase
Process, fidelity, and
acceptability:
Whether program activities were
implemented as intended and
degree to which the
intervention was implemented
as expected
What was the fidelity, dose, and
reach of the study? What was the
acceptability of implementation of
the intervention package, and of
individual items? What were the
barriers and enablers of
implementation and of
organizational change?
Inventory of CCM activities:
Level of completeness in achieving
activities of the CCM and as a
whole; Level of acceptability of the
implementation of the intervention;
Factors moderating the
implementation process (delivery
of intervention); Factors
moderating the process of
organizational change (uptake of
intervention)
Project officer reports (observation); Project
officer interviews; Team meeting notes;
Baseline and post-intensive interviews; Project
officer activity log (number of visits, time in
field)
Overall performance:
How well did the project achieve
its goals?
What were the factors associated
with success in achieving
organizational and client level
improvements in SP for RHD?
Contextual factors moderating
transfer of inputs and activities into
outputs (nonactivity enablers of
effective change)
Project officer reports (observation); Project
officer interviews; Client interview data from
ethnography study; Team meeting notes;
Baseline and maintenance-phase interviews
CCM indicates chronic care model; RHD, rheumatic heart disease; RHDSP, Rheumatic Heart Disease Secondary Prophylaxis; SP, secondary prophylaxis.
DOI: 10.1161/JAHA.118.009376 Journal of the American Heart Association 7
Evaluation of the RHDSP Trial Read et al
O
R
IG
IN
A
L
R
E
S
E
A
R
C
H
D
ow
nloaded from
 http://ahajournals.org by on September 4, 2018
Informing clients at day 21 allows them up to a week to get to
the clinic to be able to maintain adherence to a 28-day
regimen. Two clinics that changed the timing of recalls from
28 to 21 days found this to be an “easy mindset to change,”
resulting in better understanding among staff that injections
can be delivered safely before 28 days, recognition of the
value of commencing the reminder process earlier to reduce
“days at risk” of ARF recurrence, and increasing the delivery
of opportunistic injections (ie, administering a penicillin dose
if near the due date when the client attends the clinic for
other purposes). Staff noted that the change meant they “had
to ‘chase’ (clients) more often” but also that the change was
seen as a “good reminder for staff that it [benzathine
penicillin] is due.”
Increased staff training on ARF and RHD care, mostly
through completion of RHD Australia online modules,
addressed gaps in knowledge of ARF and RHD; however,
time constraints were a major barrier to completing training
modules. Regular presence of the project officers in clinics
and the process of identifying where improvements to
practice could be made had an observed positive impact on
the attitudes of some clinic staff toward RHD. During the
post–intensive phase feedback, for instance, acceptability and
benefits of the trial were articulated by healthcare providers at
some sites: “If not for this study, RHD would not be on the
radar [in the clinic]—now it’s on everyone’s radar, both
management and the other [partner] clinics” (healthcare
provider).
Interviews with clients revealed that they had many
questions about their condition and often felt powerless to
ask them within the clinic environment. This was compounded
by communication difficulties because of the need to operate
7 Tropical sites
3 Desert sites
- 1 outer regional center*
- 2 remote centers 
- 7 very remote communies      
Northern Territory 
populaon density:
Northern 
Territory:
*Remoteness classificaon: Australian Standard Geographical Classificaon
Figure 3. Map of Australia showing the Northern Territory and selected characteristics of participating communities.
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in English (not the primary language of most clients, but
interpreters are used infrequently) as well as in unfamiliar
communication styles in health services. Yet there was a
strong desire for, and a sense of exclusion from, true
knowledge. A key theme to emerge from client interviews was
that knowledge of ARF and RHD, and the reason for regular
injections, was very limited. As an example, a young woman
who had received penicillin for many years asked, “What were
the injections for?” Another young woman with recently
acquired ARF asked, “How can we stop that sickness?” The
mother of a girl with RHD asked, “Where does it come from?”
This questioning contrasted sharply with comments from
clinic staff who thought they were providing effective
education to clients, but were clearly failing: “How much
education do you give people? I mean, I feel like we’re just
giving them a lot of information that they’re paying lip service
to understanding and listening to. Either they don’t
understand, or they don’t want to listen, and that’s their
prerogative really. They expect us to create miracles and keep
them alive, yet they’re not doing their part of the bargain”
(healthcare provider).
Aboriginal participants identified that focusing on lan-
guage, place, and time could improve communication of
health information. Use of their own languages was seen as
being vital; if that were not possible—as is frequently the
case when no local Aboriginal health practitioners, commu-
nity health workers, or interpreters are available—then
information should be delivered in way that would be
understandable, drawing on and respecting traditional knowl-
edge and using appropriate analogies rather than being based
on a typical Western model of health communication. The
place they wanted to receive information was their own
space, not inside the clinic, which was often viewed as an
alienating environment. Taking time—many discussions over
Table 2. Action Items Completed During the Intensive and Maintenance Phases of the Study, According to CCM Streams
Participating Health Center
CCM Stream
Total
Clinical Information
Systems
Community
Linkages
Decision
Support
Delivery
System Design
Health
Systems
Self-Management
Support
Intensive phase
A 1 0 0 0 0 0 1
B 6 0 3 3 1 0 13
C 8 0 1 1 1 1 12
D 6 1 2 1 0 0 10
E 0 0 2 1 0 1 4
F 2 0 0 0 0 0 2
G 0 0 3 0 0 0 3
H 3 1 2 2 0 2 10
I 1 1 2 1 0 0 5
J 2 0 1 1 0 0 4
Total 29 3 16 10 2 4 64
Maintenance phase
A 1 2 0 3 0 0 6
B 3 3 2 3 0 0 11
C 4 0 0 1 0 0 5
D 2 0 2 1 0 1 6
E 2 0 1 0 0 0 3
F 7 0 2 1 0 1 11
G 0 0 0 0 0 0 0
H 0 0 0 0 0 0 0
I 0 0 0 0 0 0 0
J 0 1 2 0 0 0 3
Total 19 6 9 9 0 2 45
CCM indicates chronic care model.
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months, with a consistent person—was also requested.
When education about the need for adherence to penicillin
was delivered by the ethnographic researcher (A.G.M.)
according to these strategies, families gained a deep and
urgent sense of responsibility to ensure their children
received the treatment. On learning of the critical timing
for the penicillin injection, a grandmother of a boy with ARF
called the community clinic where her grandson was staying
to ensure they would arrange for him to receive his next
injection on time. Another grandmother, after learning of the
recommended recall at 21 days to avoid late delivery of the
penicillin injection, stated, “My daughter is looking after [boy
with RHD]. I will ring her up and tell her about counting
21 days.”
These findings reinforce the conclusion that study imple-
mentation would have been more efficient if more activities
had successfully addressed the community linkages and self-
management support themes of the CCM.
Table 3. Contextual Factors Affecting the Study’s Causal Processes and Attainment of Outcomes
Categories Explored Examples Identified Among Participating Health Centers*
Environmental Cultural disconnection between providers and consumers of health care (both language and conceptual differences)
Insufficient mechanisms to support continuum of care for Aboriginal clients traveling between communities
Complex and competing priorities within communities that distract attention from RHD and its importance (ie, underlying poverty and
dysfunction)
Organizational Competing priorities and high workload of health-center staff
High staff turnover in health centers
Inadequate infrastructure to support quality improvement processes and system redesign
Occasional difficulties with communication within and between health centers and with the control program
Culture of healthcare delivery that de-emphasized positive health-seeking behaviors among clients
Team factors Poor knowledge and awareness of RHD and the need for penicillin prophylaxis among staff in some health centers
Inconsistent senior leadership support for quality improvement
RHD indicates rheumatic heart disease.
*Most consistently identified factors shown in italics.
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Figure 4. Distribution of activities across streams of the chronic care model affecting attainment of trial outcomes. ARF indicates acute
rheumatic fever; Strike-out, insufficient success; RHD, rheumatic heart disease.
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Impact and Relevance
The study activities were often inconsistent with the per-
ceived needs of providers. The most pressing needs of
healthcare providers related to improved staffing levels, which
the intervention was not designed to address. One healthcare
provider commented, “All of these processes take thought
and time and a lot of planning. And we just don’t have it.” A
healthcare provider at another site commented, “I was quite
interested in the beginning and we could have done this, this,
and this and could’ve got really involved in it, but as I said, just
got so caught up in other things and it really just lost . . . yeah,
it lost its drive, I guess.”
Regarding relevance of the intervention to people with ARF
and/or RHD, it was difficult to discern the impact of the trial
on clients. One client, in response to questioning about
whether anything had changed about his ARF care, indicated
that he had not observed any change at all other than the
issue unrelated to the study itself of high staff turnover,
stating, “There are new nurses.”
However, some patients did perceive improvement in
access to injections outside the clinic via outreach services
and reminders from clinics. A young woman responded, “They
send me text messages and the nurse comes to see me at
home, and if I am at school, she comes to the school and
gives the injection.”
Sustainability
Action plans continued to be implemented during the
maintenance phase of the RHDSP trial, indicating potential
for sustainability. The trial’s primary end point, however, was
evaluated during the intensive phase—which provided a more
robust measure with 12 months of data across all sites—so
processes that gained momentum later were not captured in
that measure, and a longer time frame for implementing the
study may have been beneficial. Forty-five additional core
action items were completed in the maintenance phase
(Table 2). The CCM themes addressed by these later core
action items were similar in scope to those in the intensive
phase (clinical information systems, 19; delivery system
design, 9; decision support, 9; self-management support, 2;
community linkages, 6). Site H, which achieved 2 core action
items in the intensive phase, achieved 11 during the
maintenance phase. Site A, which achieved only 1 core
action item by the end of intensive phase, achieved another 6
during the maintenance phase. At the end of the trial, 71
action items remained ongoing (47 core, 24 preparatory).
At a high-performing site that engaged well with the trial, a
strong sense of ownership, pride, and sustainability relating to
the project was evident. During a post–intensive phase
feedback process, a nurse at this site stated of the project
that “we got a sense of achievement because we were making
the changes. Even though [the project officer] has gone, we
don’t need her to be ringing us up once per month because
we are continuing to make changes ourselves.”
Data obtained from the focused ethnographic study
highlighted the contrast between the stability of the local
population, which stays on traditional lands with periodic
travel between culturally linked locations, and the high churn
of nonlocal healthcare providers who were often in the
community as locum tenens staff for 2- to 6-week periods.
The constant change in clinic staffing reduced the potential
for sustainability of this CQI intervention. In this environment,
sustainability in project implementation could be provided by
the community members themselves through better self-
management support and increased employment of Aboriginal
people by health services. A project officer commented, “We
had the light bulb moment a few months into the project
where the only thing that doesn’t change is the people in the
community. So you’re trying to encourage staff to do things
better, but maybe what we need to work on is more on the
community and patient side.”
Process, Fidelity, and Acceptability
Regarding fidelity to the protocol, all participating sites
successfully developed action plans and implemented at least
1 action item during the required period. The dose of the
intervention delivered by the researchers varied between 7 of
15 monthly scheduled face-to-face visits at one site to 14 of
15 at another. One site declined to receive intervention visits
for a period because of the clinic management’s perception
that there were excessive external visitors to the community
At some sites, there was limited understanding of the
trial’s objectives and the project officers’ role (which was to
monitor and support rather than implement the action plans),
and that affected study processes: “I suppose what we would
like to see is maybe some more education from someone
outside of this clinic for our rheumatic heart patients, and
unfortunately you’re just doing the research role” (healthcare
provider).
In a project officer report, a discussion between a project
officer and a clinic manager was documented, in which the
clinic manager was quoted as saying, “We’re just not happy
with how the project is actually going and we don’t
understand why you’re not doing it the way that we thought
you were going to do it.”
Acceptability was influenced by staff attitudes toward the
benefits of specific activities, particularly those relating to
self-management support and community linkages. Also, time
required to implement RHD action plans was difficult to
incorporate into daily workloads perceived as full given
competing priorities such as acute care demands. Criticism of
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the trial included that it was too narrow, not adequately
patient centered, and not sustainable because of staff
shortages and high staff turnover at clinics: “Rheumatic heart
disease isn’t about secondary prophylaxis. It’s about whole
person and it’s about prevention. So yeah, it’s a very narrow
research project” (healthcare provider).
Servicing the needs of external groups—such as other
researchers, educators, visiting specialists, and government
agencies—placed time pressures on and added workload to
clinic staff, as highlighted by this healthcare provider’s
statement: “When we’re at a clinic you have different people
driving different programs. You’ve got rheumatic heart, then
you’ve got the renal team come in. Then you’ve got sexual
health, and they’re all competing. They’re all driving their own.
They’re passionate about their own programs. But on the coal
face [front line], basically, it can get very competitive.”
A key enabler of implementation was the presence of staff
members at clinics who displayed enthusiasm, willingness,
engagement, and motivation for the trial. An association was
apparent between the number of action items implemented
and the presence of a well-defined RHD coordinator role and/
or a clinic manager who was supportive of ARF/RHD care and
of the trial. At a clinic that implemented a high number of
action items and had high adherence at baseline and
throughout the trial, project officers noted the following
characteristics: effective communication with the jurisdic-
tional RHD control program and within the clinic; good
engagement with the community, including knowledge and
understanding of Aboriginal culture; and adequate allocation
of time by clinic management for staff to complete action
items, especially training and education.
Overall Performance
Factors affecting trial outcomes are shown in Table 3,
according to environmental, organizational, and team factors.
The interplay among these factors creates high system
complexity in the Australian NT context and provides further
reasons for the intervention implementation challenges.
Factors found to impair clinics’ abilities to change practice to
align with the intervention package were staffing issues,
including high turnover, limited opportunities for handover,
having to manage multiple portfolios, and unfilled positions;
busy jobs with high work demands causing burnout, stress,
low morale, and lack of time for staff education and other
professional development activities; and chaotic clinic envi-
ronments with internal communication failures and docu-
mented instances of tension and dispute. A nurse who
coordinated the injections in her clinic alluded to the
understaffing and unclear strategies for handover when she
was going on leave and stated, “I hope someone takes the
program on while I am away.” A project officer was asked to
provide induction for a new staff member at one clinic and
reported, “The agency nurse was not aware that one of her
roles was RHD coordinator.” Although there were many
occasions where individuals encouraged teams to make
positive changes, efforts of individuals were impeded if the
clinic environment was characterized by high staff turnover
and high workload and a culture resistant to change.
In contrast, a key factor that facilitated organizational
change and attainment of outcomes was effective clinic
management. Positive changes implemented by one clinic
manager to improve adherence for ARF and/or RHD clients
included opening the clinic through lunch hours; providing
opportunities for staff to shift portfolios, if they wished (eg,
from acute to chronic care management); encouraging staff to
identify areas they would like to improve with goal setting and
provision of strategies to support goals; and providing positive
feedback to staff.
Discussion
We undertook a comprehensive evaluation of the RHDSP
community randomized trial to improve the delivery of
penicillin as secondary prophylaxis for Aboriginal people with
ARF and/or RHD in Australia’s NT. Findings reveal factors
pertaining to the project design, implementation, and context
that contributed to a lack of improved adherence. A chief
project design factor identified was the relatively short time
allocated in which to implement and measure the primary
outcome. The chief implementation factor was that action
items addressing the self-management support and commu-
nity linkage themes of the CCM proved very difficult to
conceptualize, let alone achieve, and the number and quality
of action items were insufficient to activate change. The chief
contextual factors were staffing challenges in remote settings
(understaffing and high turnover) and the sociocultural
environment, characterized by cultural and language differ-
ences between healthcare providers and Aboriginal clients,
resulting in impaired communication; ultimately, the health
care being provided was not seen by the end users in this
study (Aboriginal people) as meeting their needs.
The trial design underestimated the time needed to
implement activities that could result in genuine change.
The duration of the project implementation phase was
15 months. Although the stepped-wedge design provided a
3-month transition period before commencement of the 12-
month intensive phase of quantitative data collection, this
total 15-month intervention period was evidently not long
enough. Action items continued to be implemented during the
maintenance phase of the trial and thereafter, indicating
ongoing momentum and potential for sustainability, which is
supported by the finding of improved secondary prophylaxis
delivery in the maintenance period compared with the
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intervention period. Other CQI interventions in the NT have
found the number of years of participation in CQI audit cycles
to be a main determinant of success.19
Regarding difficulties in implementing action items, partic-
ularly those to effectively engage clients (self-management
support) and the community (community linkages), barriers
included lack of time available for healthcare providers to
undertake these time-consuming tasks and sociocultural/
linguistic disconnection between largely non-Aboriginal
healthcare systems and Aboriginal people. Clinicians are
generally trained to operate within the confines of a clinic
according to their medical and nursing training; it is perhaps
unreasonable to expect clinicians (often short-term and acute-
care focused) to operate outside their usual scope of clinical
practice to take a lead role in forging community linkages,
especially amid competing demands on time. Yet Aboriginal
clients consistently articulate that they feel alienated by the
very services intended to care for them. Quotations from the
client and healthcare provider interviews related earlier
provide clear examples of failures in implementation of
genuine self-management support. Major revisions in models
of care are needed in the Australian NT context to better meet
the needs of Aboriginal people.20,21 Healthcare providers
operating in this culturally and linguistically unique environ-
ment require far more training about how to engage
effectively with their clients. The value of Aboriginal gover-
nance and leadership within healthcare services and research
has recently been emphasized.22 Our trial had Aboriginal
leadership among the initial investigator team, but their
involvement could not be continued because of high compet-
ing priorities—a problem frequently encountered by in-
demand Aboriginal researchers. Follow-up studies are now
under way working closely with Aboriginal researchers to
foster community linkages in ARF/RHD research.
Regarding implementation challenges, we aimed to support
action items that would durably embed change in medical
records software (recall systems, flagging ARF/RHD patients
and disease severity, supporting linkage of electronic health
records) and sought to engage clinic management in CQI
feedback. However, staff knowledge and education (including
completing training in ARF/RHD management) is nondurable
when staff are replaced; this presents an ongoing challenge
and is a well-recognized problem. A recent study found that
only 20% of nurses and Aboriginal healthcare providers
remained working at surveyed remote clinics 12 months after
commencing, with half having left within 4 months.23 Under-
staffing and high turnover also affects the “readiness for
change” of health systems, and the acceptability of quality-
improvement projects such as this one, which require active,
long-term participation from healthcare providers. In part
because of staff turnover, not all sites clearly understood the
trial’s methods and the role of the project officers despite a
thorough baseline consultation and consent process and
efforts by the project team to communicate effectively with
participating sites though trial newsletters, printed trial
materials, face-to-face workshops, telephone support, and
email.
Limitations of this evaluation include that serial interviews
with the same healthcare provider to track evolving attitudes
to the project were rarely possible given staff turnover; only
24 clinic staff members of the original 107 interviewed were
available for a follow-up interview. The nested ethnographic
study that provided the patient data was essentially a
convenience sample based on accessibility of the community
or language spoken; this approach may have limited the
diversity of data captured. The 4 sites selected differed
greatly from each other in their historical, cultural, and
language characteristics, but the data obtained should not be
considered to represent patient views across all 10 study
sites. The ethnographic component was chiefly able to
provide data on experiences of ARF/RHD and health care in
general, rather than impact of the project per se.
Findings of this evaluation have high relevance for delivery
of ARF and/or RHD care internationally. First, that CQI
interventions need to be implemented for an adequate
duration to effect change in primary care settings is shown
here, supported by other recent studies applying CQI
processes.19,24 Second, this evaluation illustrates the critical
importance of cultural competence within health systems,
especially when tackling diseases of disparity such as RHD,
which predominantly affects Indigenous and disadvantaged
populations globally. Third, use of the CCM to guide the
delivery of care for RHD and other chronic conditions has
international relevance; this intervention provides a range of
examples of activities to consider across the CCM streams.
We applied the CCM to delivery of secondary prophylaxis, but
elements of this model also apply to primary prevention:
Successful programs implemented to reduce RHD rates in the
United States in the 1970s,25 in Cuba between the 1980s and
2000s,26 and in the French Caribbean islands in the 1990s27
were achieved using comprehensive strategies that included
examples of community linkages such as awareness-raising
campaigns for affected populations. More recently, school-
based primary prevention programs (also an example of
community linkages) using active case finding and school-
based delivery of treatment for streptococcal infections have
been reported to be associated with reduced ARF rates.28
Comprehensive approaches at all public health levels from
primordial through primary, secondary, and tertiary are highly
applicable to RHD prevention. We are now testing a model of
care in which Aboriginal community workers are employed as
“care navigators” to work at the interface between medical
services and families affected by RHD, to support adherence
and other aspects of care.29
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Conclusion
By applying a comprehensive mixed-methods evaluation to this
trial, we were able to discern that the program theory
underpinning the study appeared sound, but the limited impact
made by the study on adherence was attributable to complex
implementation challenges. Secondary prevention of ARF
recurrences with penicillin prophylaxis is vital to reduce the
global burden of RHD, but delivery of this regimen poses
substantial challenges for health systems and clients. The
multifaceted intervention we implemented was associated with
some important gains, including improved adherence in a
subset of clients and sustainability of health system-strength-
ening approaches at some participating sites, but it did not
improve adherence overall. Improving chronic condition man-
agement in primary care requires a comprehensive approach to
chronic care management, especially to activities fostering
client and community engagement. These evaluation findings
provide strong support for newmodels of patient-centered care
to be implemented in Australian Aboriginal communities and in
all settings with high burdens of ARF and RHD.
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